1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches
It may surprise you to learn that many donated organs never get used. Less than a third of donated hearts and less than a quarter of donated lungs end up making their way to a recipient. But a company called TransMedics (NASDAQ: TMDX) hopes to change that, looking to disrupt the way organs are transplanted by transforming the way donated organs are procured and stored for delivery.
Currently in the U.S., after organs are harvested from a donor, they are stored in cold temperatures for transport. During transport, which can often take several hours, organs can deteriorate until they are no longer usable. But with TransMedics' Organ Care System (OCS), each organ can be continuously monitored and optimized for a successful donation during transport. With the TransMedics OCS, post-transplant complication rates are significantly decreased for heart and lung transplants, from a range of 30% to 35% to just 10%-14%.
Image source: Getty Images.
Source Fool.com
